ConductScience.org, home

Paper36901762

PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases.

Guo X and 8 others. Int J Mol Sci, 2023. Cited by 71 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases. Papers, record 36901762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901762

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
9.8
iCite
Revised in PubMed
2023-03-14
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guo XXiaoping
2Zuo XXu
3Zhou ZZhengjie
4Gu YYinuo
5Zheng HHaoyu
6Wang XXinlei
7Wang GGuoqiang
8Xu CCaina
9Wang FFanghttps://orcid.org/0000-0003-0871-3454

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NanoparticlesMajor topic
Respiration DisordersMajor topic
Respiratory Tract DiseasesMajor topic
AsthmaMajor topic
Pulmonary Disease, Chronic ObstructiveMajor topic
Humans
Polylactic Acid-Polyglycolic Acid Copolymer
Polyglycolic Acid
Lactic Acid
Drug Carriers

Source PubMed

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NO. 3D5200117426Jilin Provincial Key Laboratory of Pathogen BiologyPubMed
NO.20200601011JCKey Laboratory of Precision Infectious Diseases of Jilin ProvincePubMed
NO. 3J1222527426Jilin Provincial Development and Reform Commission Common Disease Precision Prevention and Control Engineering LaboratoryPubMed
52073278National Natural Science Foundation of ChinaPubMed
2022JBGS10"Medical Science + X" cross-innovation team of the Norman Bethune Health Science of Jilin Uni-versityPubMed
2021JC036Health Commission of Jilin ProvincePubMed
noSpecial Funding for Fundamental Scientific Research Business Expenses of Central UniversitiesPubMed

Source PubMed

References210

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135,015,036What Is Cystic Fibrosis?JAMA2022https://conductscience.org/library/papers/35015036PubMed
229,466,596Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment.JAMA2018https://conductscience.org/library/papers/29466596PubMed
326,333,936Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation.Sci Transl Med2015https://conductscience.org/library/papers/26333936PubMed
427,825,867Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.Int J Pharm2017https://conductscience.org/library/papers/27825867PubMed
515,762,319Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.J Microencapsul2004https://conductscience.org/library/papers/15762319PubMed
624,275,949RNAi Therapeutic Platforms for Lung Diseases.Pharmaceuticals (Basel)2013https://conductscience.org/library/papers/24275949PubMed
732,606,658Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers.Int J Nanomedicine2020https://conductscience.org/library/papers/32606658PubMed
822,561,837Therapies for allergic inflammation: refining strategies to induce tolerance.Nat Med2012https://conductscience.org/library/papers/22561837PubMed
933,809,764PLGA Based Nanospheres as a Potent Macrophage-Specific Drug Delivery System.Nanomaterials (Basel)2021https://conductscience.org/library/papers/33809764PubMed
1032,648,899Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.JAMA2020https://conductscience.org/library/papers/32648899PubMed
1119,162,482Preventing biofilms of clinically relevant organisms using bacteriophage.Trends Microbiol2009https://conductscience.org/library/papers/19162482PubMed
1215,970,469Infection and inflammation in cystic fibrosis: a short review.J Cyst Fibros2005https://conductscience.org/library/papers/15970469PubMed
1322,489,704Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery.Mol Pharm2012https://conductscience.org/library/papers/22489704PubMed
1434,582,183Lung-Targeting Lysostaphin Microspheres for Methicillin-Resistant Staphylococcus aureus Pneumonia Treatment and Prevention.ACS Nano2021https://conductscience.org/library/papers/34582183PubMed
1526,952,014Development and assessment of countermeasure formulations for treatment of lung injury induced by chlorine inhalation.Toxicol Appl Pharmacol2016https://conductscience.org/library/papers/26952014PubMed
1635,390,488Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: Effects of nanoparticle properties.Int J Pharm2022https://conductscience.org/library/papers/35390488PubMed
1734,112,203Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19.J Nanobiotechnology2021https://conductscience.org/library/papers/34112203PubMed
1836,016,948Advances in the use of exosomes for the treatment of ALI/ARDS.Front Immunol2022https://conductscience.org/library/papers/36016948PubMed
1933,376,321Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.Int J Nanomedicine2020https://conductscience.org/library/papers/33376321PubMed
2028,404,617Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.BMJ2017https://conductscience.org/library/papers/28404617PubMed

See all 210 references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
42,808,126Nanostructure driven innovation in diabetes: from enhanced biosensing to smart therapeutic delivery.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42808126PubMed
42,694,977Deficiency of GLUT1 in macrophages reprograms tumor-associated macrophages to normalize tumor vasculature and retards the progression of tumors.Int J Biol Sci2026https://conductscience.org/library/papers/42694977PubMed
42,675,037Precision nanomedicine for pulmonary diseases: from molecular targeting to clinical translation.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42675037PubMed
42,514,899Beyond Antibiotics: The Role of Antimicrobial Polymers in Modern Therapeutics.Pharmaceutics2026https://conductscience.org/library/papers/42514899PubMed
41,852,888Polymeric anti-platelet carriers for the precision-targeting of age-related cardiovascular and cerebrovascular diseases.Mater Today Bio2026https://conductscience.org/library/papers/41852888PubMed
41,807,762Continuous Electrospraying of Inhalable Biological Drug Products: Novel Formulation and Manufacturing Technology.Pharm Res2026https://conductscience.org/library/papers/41807762PubMed
41,775,929Advancing Rare Cancer Therapeutics: Osimertinib-Loaded Inhaled PLGA Nanoparticles for Mesothelioma Treatment.AAPS PharmSciTech2026https://conductscience.org/library/papers/41775929PubMed
41,533,007PLGA nanoparticles restore acidic pH and degradative function to compromised lysosomes with Cy3-labeling providing enhanced tracking to lysosomes.Am J Physiol Cell Physiol2026https://conductscience.org/library/papers/41533007PubMed
41,510,735Formulation Development and In vitro Characterization of Nanoparticles of Pazopanib for Wet Macular Degeneration.Curr Drug Deliv2026https://conductscience.org/library/papers/41510735PubMed
41,497,188Advances in PLGA-Based Drug Delivery Systems for Glioblastoma Treatment.Int J Nanomedicine2025https://conductscience.org/library/papers/41497188PubMed
41,393,117Emerging drug delivery approach using nanomaterials for the treatment of endometrial cancer.Front Med Technol2025https://conductscience.org/library/papers/41393117PubMed
41,273,167Evaluating the Antiviral Efficacy of Encapsulated PKC Inhibitor BIM-I against influenza A Virus Infection.Adv Healthc Mater2026https://conductscience.org/library/papers/41273167PubMed
41,269,573Advances in nanostructured drug delivery systems for cardiovascular therapeutics.Daru2025https://conductscience.org/library/papers/41269573PubMed
41,230,148Prophylactic adjuvant therapy for postoperative recurrence of urethral stricture: a narrative review.Transl Androl Urol2025https://conductscience.org/library/papers/41230148PubMed
41,058,938Targeting Multiple Pathophysiological Axes in COPD: Nanomaterial Advances.Int J Nanomedicine2025https://conductscience.org/library/papers/41058938PubMed
41,012,548Glycyrrhiza uralensis Polysaccharide Gold Nanoparticles as Antigen Carriers and Potential Adjuvant to DC Vaccines.Pharmaceutics2025https://conductscience.org/library/papers/41012548PubMed
40,898,368Novel pharmaco-exosomal immunotherapy for united airway diseases: PLGA-encapsulated, mesenchymal stem cell-derived exosomes with PPAR-γ agonist for allergic rhinitis and asthma.Stem Cell Res Ther2025https://conductscience.org/library/papers/40898368PubMed
40,844,759Amino Acid Transporters in Glioblastoma: Implications for Diagnosis, Disease Monitoring, Therapeutic Targeting, and Drug Delivery.Mol Diagn Ther2025https://conductscience.org/library/papers/40844759PubMed
40,723,881A Novel Microencapsulated Bovine Recombinant Interferon Tau Formulation for Luteolysis Modulation in Cattle.Biomolecules2025https://conductscience.org/library/papers/40723881PubMed
40,702,523PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy.Mol Cancer2025https://conductscience.org/library/papers/40702523PubMed

See all 46 cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CFTR1,080PubTator's text mininghttps://conductscience.org/library/genes/1080NCBI Gene
CRYAB1,410PubTator's text mininghttps://conductscience.org/library/genes/1410NCBI Gene
HLA-A3,105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
IGHE3,497PubTator's text mininghttps://conductscience.org/library/genes/3497NCBI Gene
IL1R13,554PubTator's text mininghttps://conductscience.org/library/genes/3554NCBI Gene
IRAK13,654PubTator's text mininghttps://conductscience.org/library/genes/3654NCBI Gene
MIR146A406,938PubTator's text mininghttps://conductscience.org/library/genes/406938NCBI Gene
TNFAIP37,128PubTator's text mininghttps://conductscience.org/library/genes/7128NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36901762

GET https://conductscience.org/api/papers/v1/36901762/references?page=2